GLOBUS MEDICAL INC (GMED)
Globus Medical Inc. (GMED) is a leading medical device company specializing in the design, development, and commercialization of innovative products for the spine, trauma, and other orthopedic markets. Founded in 2003 and headquartered in Audubon, Pennsylvania, the company focuses on advancing patient care through its extensive portfolio of surgical solutions and technological innovations aimed at treating musculoskeletal conditions.
Company News
Globus Medical announced leadership transitions, with Keith Pfeil becoming President and CEO, replacing Dan Scavilla. Kyle Kline was appointed as the new CFO. The company reported preliminary Q2 2025 sales of $745.3 million, an 18.4% increase from the previous year.
Globus Medical, a leading musculoskeletal technology company, has completed the acquisition of Nevro Corp., a global medical device company that specializes in the treatment of chronic pain. The acquisition expands Globus Medical's presence in the musculoskeletal market and provides access to Nevro's differentiated high-frequency technology.
Thermo Fisher Scientific reported better-than-expected Q2 2024 results, with adjusted EPS of $5.37 and revenue of $10.54 billion. The company saw margin expansion but a decline in both reported and organic revenues, particularly in the Life Sciences Solutions and Laboratory Products and Biopharma Services segments.
Globus Medical director Leslie V. Norwalk sold 1,000 shares of the company's Class A Common Stock for $70,000. The transaction was conducted under a pre-arranged trading plan, adjusting Norwalk's direct holdings to 16,419 shares.
GMED earnings call for the period ending March 31, 2024.